What is the JAK2-V617F mutation and its significance in polycythemia vera?

The JAK2-V617F mutation is a genetic alteration commonly associated with polycythemia vera, a type of myeloproliferative disorder. This mutation leads to uncontrolled production of blood cells, which can increase the risk of blood clots and other cardiovascular complications. Understanding this mutation is crucial for diagnosis and treatment planning in patients with polycythemia vera, as it allows healthcare providers to tailor therapies based on the mutation's presence.

Who is typically affected by polycythemia vera and the JAK2-V617F mutation?

Polycythemia vera primarily affects adults, with the highest incidence in individuals aged 60 and older. However, it can occur in younger individuals as well. The JAK2-V617F mutation is found in approximately 95% of polycythemia vera cases, making it a reliable biomarker for diagnosis. Individuals with a family history of blood disorders or a previous history of blood clots may have a higher risk.

How is the JAK2-V617F mutation tested?

Testing for the JAK2-V617F mutation typically involves a blood sample analysis through polymerase chain reaction (PCR) techniques. This method allows for the detection of the specific genetic change in the JAK2 gene. The results help in confirming a diagnosis of polycythemia vera and can guide subsequent management and treatment decisions.

What are the common symptoms of polycythemia vera related to the JAK2-V617F mutation?

Individuals with polycythemia vera often experience symptoms such as headaches, dizziness, and blurred vision due to increased blood viscosity. Other symptoms may include fatigue, itching after a hot shower, and a ruddy complexion. Recognizing these symptoms is crucial for early intervention, which can help manage complications arising from the mutation.

Can the JAK2-V617F mutation be inherited?

The JAK2-V617F mutation is not directly inherited in a traditional sense, as it generally occurs sporadically during an individual’s lifetime. However, familial predispositions to myeloproliferative disorders may exist, indicating that genetic factors could play a role in risk. Understanding family medical history can aid in assessment and early detection of disorders associated with this mutation.

What treatment options are available for patients with the JAK2-V617F mutation?

Treatment options for patients with the JAK2-V617F mutation primarily focus on controlling symptoms and reducing the risk of complications. Common approaches include phlebotomy to reduce red blood cell mass, low-dose aspirin to mitigate thrombotic risks, and newer targeted therapies like JAK inhibitors. These treatments may help significantly reduce symptoms and improve the quality of life for affected patients.

How does the JAK2-V617F mutation impact the prognosis of polycythemia vera?

The presence of the JAK2-V617F mutation generally provides a clearer understanding of the disease and can influence prognosis. Patients with this mutation may respond better to certain targeted therapies, leading to improved management of the condition. Continuous monitoring and a personalized treatment approach can lead to a more favorable outcome, emphasizing the importance of early detection and regular follow-ups.

What role does genetic counseling play for patients with the JAK2-V617F mutation?

Genetic counseling is vital for patients with the JAK2-V617F mutation, offering support in understanding the implications of the mutation on health, family planning, and potential risks. It helps patients make informed decisions regarding their care and empowers them to take proactive steps in managing their health condition in collaboration with their healthcare providers.

Where can I buy 'JAK2-V617F Mutation In Polycythemia Vera Of Australia: Evaluation of patients with myeloproliferative disorders' in Australia?

You can purchase 'JAK2-V617F Mutation In Polycythemia Vera Of Australia: Evaluation of patients with myeloproliferative disorders' through Ubuy in Australia. Ubuy offers a convenient online shopping platform with access to various genetic research materials and books, ensuring that you can find the specific literature you're looking for with ease.

How to Shop JAK2-V617F Mutation In Polycythemia Vera Of Iran: Online From Ubuy?

It’s easy to shop JAK2-V617F Mutation In Polycythemia Vera Of Iran: online from Ubuy. You just have to search for the product, choose your shipping method while checking out and get it delivered to your location.

Is JAK2-V617F Mutation In Polycythemia Vera Of Iran: Available to Shop Online in Australia?

Yes, at Ubuy Australia this product is available for you to shop at a reasonable price. The JAK2-V617F Mutation In Polycythemia Vera Of Iran: is not available locally but you can trust us with our express shipping services.

How Long Does It Take to Get Product After Placing the Order?

The delivery time of your ordered product varies as per what you've ordered and the shipping method that you've chosen. The estimated delivery time is mentioned during the checkout process, so be carefree while shopping.

JAK2-V617F Mutation In Polycythemia Vera Of Iran: Evaluation of patients with myeloproliferative disorders Genetic mutation JAK2-V617F in polycythemia vera in the TABRIZ

Genetic studies in the future we hope to be able to cure this disease is very dangerous.

Item #: 47190560

JAK2-V617F Mutation In Polycythemia Vera Of Iran: Evaluation of patients with myeloproliferative disorders Genetic mutation JAK2-V617F in

99% of respondents would recommend this to a friend

Item #: 47190560

AUD 187

Price Details

Excluding Shipping & Custom charges ( Shipping and custom charges will be calculated on checkout )

^{*All items will import from US}

Availability : In stock

Imported from USA store

QTY:

Order now and get it around Friday, September 25

Secured transaction

Our Top Logistics Partners

Genetic studies in the future we hope to be able to cure this disease is very dangerous.

U-Care Warranty:

None

Select a Plan

Buy Now Pay Later

Fast
Shipping

Free
Return^*

Secure Packaging

100% Original Products

PCI DSS Compliance

ISO 27001 Certified

Note: Step Down Voltage Transformer required for using electronics products of US store (110-120). Recommended power converters Buy Now.

What Stands Out

Targeted Research

Focuses on the JAK2-V617F mutation in patients with Polycythemia Vera in Iran, providing crucial insights for healthcare professionals addressing myeloproliferative disorders.

Cultural Context

Analyzes genetic mutations within the specific genetic and environmental context of Iranian patients, enhancing understanding of regional health challenges and improving tailored treatment options.

Clinical Relevance

Presents relevant findings that can directly inform clinical practices and assist in the development of targeted therapies, ultimately enhancing patient care and outcomes.

Product Details

Country of Origin	This item will be imported from US
Item Weight	1 lbs (450 grams)
What is in the box	JAK2-V617F Mutation In Polycythemia... For more details, please check description/product details

Who Should Buy?

Healthcare Professionals
Doctors and researchers studying myeloproliferative disorders can gain valuable insights from this comprehensive evaluation.
Genetics Students
Students specializing in genetics will find this book useful for understanding specific mutations and their implications for diseases.
Patients & Families
Individuals affected by polycythemia vera may find the information beneficial for understanding their condition and potential treatments.

General Audience
Individuals without a medical or scientific background may find the content too technical and difficult to understand.

Product Description

JAK2-V617F Mutation In Polycythemia Vera Of Iran: Evaluation of patients with myeloproliferative disorders Genetic mutation JAK2-V617F in polycythemia vera in the TABRIZ

Have any Query? Chat with us

Customer Questions & Answers

Question: How to Shop JAK2-V617F Mutation In Polycythemia Vera Of Iran: Online From Ubuy?

Answer: It’s easy to shop JAK2-V617F Mutation In Polycythemia Vera Of Iran: online from Ubuy. You just have to search for the product, choose your shipping method while checking out and get it delivered to your location.
Question: Is JAK2-V617F Mutation In Polycythemia Vera Of Iran: Available to Shop Online in Australia?

Answer: Yes, at Ubuy Australia this product is available for you to shop at a reasonable price. The JAK2-V617F Mutation In Polycythemia Vera Of Iran: is not available locally but you can trust us with our express shipping services.
Question: How Long Does It Take to Get Product After Placing the Order?

Answer: The delivery time of your ordered product varies as per what you've ordered and the shipping method that you've chosen. The estimated delivery time is mentioned during the checkout process, so be carefree while shopping.

Genetics Editorial Review

No editorial reviews found

Customer Reviews & Ratings

5.0

1 customers ratings

5 Star

100%
4 Star

0%
3 Star

0%
2 Star

0%
1 Star

0%

Review this product

Share your thoughts with other customers

Product Price History

Important information

Limitations : For products shipped internationally, please note that any manufacturer warranty may not be valid; manufacturer service options may not be available; product manuals, instructions, and safety warnings may not be in destination country languages; the products (and accompanying materials) may not be designed in accordance with destination country standards, specifications, and labeling requirements; and the products may not conform to destination country voltage and other electrical standards (requiring use of an adapter or converter if appropriate). The recipient is responsible for assuring that the product can be lawfully imported to the destination country. When ordering from Ubuy or its affiliates, the recipient is the importer of record and must comply with all laws and regulations of the destination country.
Not all the products listed on Ubuy are for sale, as Ubuy is a global search engine. Products are subject to export/trade regulations.

AUD 187

Order now and get it around Friday, September 25

QTY:

Secured transaction

PCI DSS compliant and ISO 27001:2022 certified, with encrypted payments and full buyer protection on every order.

Our Top Logistics Partners

Fastest cross-border delivery

Features & Benefits

Explore JAK2-V617F mutation's impact on polycythemia vera.
Focus on hematological infectious diseases, including polycythemia.
Identify the need for more research to address this growing issue.
Highlight the increasing number of deaths due to polycythemia each year.
Discuss the significance of chronic myeloproliferative disorders (MPDs).
Emphasize potential breakthroughs from genetic studies for future cures.

Ubuy Assurance

Experience worry-free shopping with 100% original products, PCI DSS-compliant payment security, ISO 27001-certified data protection, the fastest cross-border delivery, free returns ^*, and secure packaging on every order.

JAK2-V617F Mutation In Polycythemia Vera Of Iran: Evaluation of patients with myeloproliferative disorders Genetic mutation JAK2-V617F in

AUD 187

Buy Now Pay Later

Fast Shipping

Free Return*

Secure Packaging

100% Original Products

PCI DSS Compliance

ISO 27001 Certified

What Stands Out

Product Details

Who Should Buy?

Product Description

Customer Questions & Answers

Genetics Editorial Review

Customer Reviews & Ratings

Review this product

Product Price History

Important information

AUD 187

Features & Benefits

Ubuy Assurance

Fast
Shipping

Free
Return^*